Role of Hyperinsulinemia in NAFLD Pathogenesis: Dexamethasone/Pancreatic Clamp Pilot & Feasibility Study (Obesity)
Pancreatic Clamp Study: Lowering Insulin Levels During Temporary Insulin Resistance
Sponsor: Dr. Joshua Cook
Enrolling: Male and Female Patients
Study Length: 6 Weeks
Clinic Visits: 3
IRB Number: AAAU7680
Contact: Zachary Sone: 212-305-9336 / zds2120@cumc.columbia.edu
Additional Study Information: We're conducting a research study on how much insulin is needed to control blood sugar in people who are made temporarily resistant to insulin's effects. Insulin is the main hormone (chemical signal) that the body uses to lower the levels of sugar in the blood. We are interested in looking at insulin levels because we think that lowering insulin levels may be a way to treat people with excessive fat in their liver (called "fatty liver disease"). Before we look at liver fat, though, we need to know how lowering insulin levels affects blood sugar. We're seeking adult volunteers, aged 18-65, who are overweight or obese with a body mass index of 25.0-39.9 but have not been diagnosed with prediabetes or diabetes. Participants will undergo two pancreatic clamp procedures separated by 2-4 weeks after being made temporarily insulin resistant by taking a steroid pill called dexamethasone for 2 days. A pancreatic clamp is a technique in which we temporarily shut off the body's production of insulin with intravenous (into the vein) hormone mixtures that allow researchers to vary levels of insulin, over about 7 hours. Participants will be required to stay in the hospital overnight before the clamp. We'll perform blood tests during the procedure to look at levels of glucose (sugar), insulin, and certain fats. The goal is to see how lowering the insulin level by different amounts affects blood sugar levels while someone is temporarily resistant to insulin's effects. In one of the clamps, we'll lower the level of insulin incrementally, while in the other we will keep it the same throughout. The order that you would go through the two different clamps would be at random (like tossing a coin). Participants will attend an outpatient screening visit plus two inpatient visits of up to 30 hours each, and will be compensated up to a total stipend (salary) of $850 plus additional reimbursement for travel expenses.
This study is closed
Investigator
Joshua Cook, MD, PhD
Do You Qualify?
Are you able to stay overnight in the hospital twice within 2-4 weeks? Yes No
Is your BMI between 25 and 39.9? Yes No
Are you willing to take 7 doses of dexamethasone (steroid pill) over 48 hours before each pancreatic clamp? Yes No
Are you okay with receiving medications through veins and having your blood drawn? Yes No
Women under 51 do you use birth control (pills/implant/IUD/surgical), even if abstinent? (Men & women over 50: answer Yes) Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Zachary Sone
zds2120@cumc.columbia.edu
212-305-9336